首页 > 最新文献

Acta Anaesthesiologica Scandinavica最新文献

英文 中文
The adverse effects with ibuprofen after major orthopedic surgeries: A protocol for the PERISAFE randomized clinical trial. 大型骨科手术后布洛芬的不良反应:PERISAFE随机临床试验方案
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14578
Christina Cleveland Westerdahl Laursen, Troels Haxholdt Lunn, Daniel Hägi-Pedersen, Anne Sofie Nautrup Therkelsen, Claus Varnum, Kai Henrik Wiborg Lange, Müjgan Yilmaz, Niels Anker Pedersen, Andreas Kappel, Thomas Jakobsen, Salamah Belal Eljaja, Thomas Thougaard, Ben Kristian Graungaard, Thomas Bjerno, Jacob Beck, Charlotte Runge, Joakim Steiness, Kasper Smidt Gasbjerg, Kasper Højgaard Thybo, Stig Brorson, Martin Lindberg-Larsen, Søren Overgaard, Janus Christian Jakobsen, Ole Mathiesen

Introduction: Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended for pain treatment after elective hip and knee arthroplasties. However, evidence regarding the incidence of adverse effects with short-term NSAID treatment following surgery is limited. We, therefore, aim to assess the adverse effects with an eight-day postoperative treatment with ibuprofen after elective hip and knee arthroplasties.

Methods and analysis: PERISAFE is a randomized, placebo-controlled, blinded multicenter trial with 90-day and one-year follow-up. Eligible patients undergoing elective hip or knee arthroplasty are allocated 1:1 to either ibuprofen 400 mg ×3/day or identical placebo ×3/day for eight days after surgery. The primary outcome is a composite of either death, acute myocardial infarction, stroke, pulmonary embolism, deep venous thrombosis, renal failure, major bleeding, re-operation, gastrointestinal ulcer, or readmission within 90 days postoperatively. Secondary outcomes are hospital-free days within 90 days postoperatively, a composite of ibuprofen and opioid-related adverse reactions based on eight-day postoperative diary, and health related quality of life after 90 days postoperatively. A total of 2904 patients are needed to demonstrate a relative risk reduction of 33% in the placebo group, accepting a risk of type I error of 5% and type II error of 20% and a proportion of serious adverse events in the ibuprofen group of 8%. The primary analysis will be in the modified intention-to-treat population.

Ethics and dissemination: The trial is approved by the Danish Medicine Agency and the Research Ethics Committee (EU CT no. 2022-502, 502-32-00). We plan to submit for publication in a major international peer-reviewed journal and present results at scientific meetings.

介绍:非甾体抗炎药(NSAIDs)被推荐用于选择性髋关节和膝关节置换术后的疼痛治疗。然而,关于手术后短期非甾体抗炎药治疗不良反应发生率的证据有限。因此,我们的目的是评估选择性髋关节和膝关节置换术后8天布洛芬治疗的不良反应。方法和分析:PERISAFE是一项随机、安慰剂对照、多中心盲法试验,随访90天和1年。接受选择性髋关节或膝关节置换术的符合条件的患者在术后8天内按1:1的比例分配布洛芬400 mg ×3/天或相同的安慰剂×3/天。主要结局是死亡、急性心肌梗死、中风、肺栓塞、深静脉血栓形成、肾功能衰竭、大出血、再手术、胃肠道溃疡或术后90天内再入院的综合结果。次要结局是术后90天内的无住院天数,术后8天日记中布洛芬和阿片类药物相关不良反应的综合,以及术后90天内与健康相关的生活质量。总共需要2904例患者才能证明安慰剂组相对风险降低33%,接受I型错误风险为5%,II型错误风险为20%,布洛芬组严重不良事件比例为8%。主要的分析将在意向治疗人群中进行。伦理和传播:该试验得到了丹麦医学机构和研究伦理委员会(EU CT no. 5)的批准。2022 - 502, 502-32-00)。我们计划在一个主要的国际同行评审期刊上发表,并在科学会议上展示结果。
{"title":"The adverse effects with ibuprofen after major orthopedic surgeries: A protocol for the PERISAFE randomized clinical trial.","authors":"Christina Cleveland Westerdahl Laursen, Troels Haxholdt Lunn, Daniel Hägi-Pedersen, Anne Sofie Nautrup Therkelsen, Claus Varnum, Kai Henrik Wiborg Lange, Müjgan Yilmaz, Niels Anker Pedersen, Andreas Kappel, Thomas Jakobsen, Salamah Belal Eljaja, Thomas Thougaard, Ben Kristian Graungaard, Thomas Bjerno, Jacob Beck, Charlotte Runge, Joakim Steiness, Kasper Smidt Gasbjerg, Kasper Højgaard Thybo, Stig Brorson, Martin Lindberg-Larsen, Søren Overgaard, Janus Christian Jakobsen, Ole Mathiesen","doi":"10.1111/aas.14578","DOIUrl":"10.1111/aas.14578","url":null,"abstract":"<p><strong>Introduction: </strong>Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended for pain treatment after elective hip and knee arthroplasties. However, evidence regarding the incidence of adverse effects with short-term NSAID treatment following surgery is limited. We, therefore, aim to assess the adverse effects with an eight-day postoperative treatment with ibuprofen after elective hip and knee arthroplasties.</p><p><strong>Methods and analysis: </strong>PERISAFE is a randomized, placebo-controlled, blinded multicenter trial with 90-day and one-year follow-up. Eligible patients undergoing elective hip or knee arthroplasty are allocated 1:1 to either ibuprofen 400 mg ×3/day or identical placebo ×3/day for eight days after surgery. The primary outcome is a composite of either death, acute myocardial infarction, stroke, pulmonary embolism, deep venous thrombosis, renal failure, major bleeding, re-operation, gastrointestinal ulcer, or readmission within 90 days postoperatively. Secondary outcomes are hospital-free days within 90 days postoperatively, a composite of ibuprofen and opioid-related adverse reactions based on eight-day postoperative diary, and health related quality of life after 90 days postoperatively. A total of 2904 patients are needed to demonstrate a relative risk reduction of 33% in the placebo group, accepting a risk of type I error of 5% and type II error of 20% and a proportion of serious adverse events in the ibuprofen group of 8%. The primary analysis will be in the modified intention-to-treat population.</p><p><strong>Ethics and dissemination: </strong>The trial is approved by the Danish Medicine Agency and the Research Ethics Committee (EU CT no. 2022-502, 502-32-00). We plan to submit for publication in a major international peer-reviewed journal and present results at scientific meetings.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14578"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143062906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conus medullaris termination: Assessing safety of spinal anesthesia in the L2-L3 interspace. 脊髓圆锥终止:评估L2-L3间隙脊髓麻醉的安全性。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14580
James E Paul, Lisa A Udovic, Kathleen Oman, Thomas Kim, Leora Bernstein, Luigi Matteliano, Nina Singh, Alexa Caldwell, Thuva Vanniyasingam, Lehana Thabane

Background: Classic teaching is that spinal anesthesia is safe at or below the L2-L3 interspace. To evaluate this, we sought to determine the percentage of individuals with a conus medullaris termination (CMT) level at or below the L1-L2 interspace. Further, the relationship of CMT level to age, sex, body mass index (BMI), and spinal pathology was examined, as was the reliability of using Tuffier's line (TL) as an anatomical landmark.

Methods: This retrospective study evaluated magnetic resonance images of 944 adult patients to determine the CMT level. The relationship between age, sex, height, BMI, and spinal pathology and CMT level was explored by logistic regression. The correspondence of the TL line to the L4-L5 interspace and the presence of overlap with the CMT were examined using 720 lumbar x-rays of the same patient cohort.

Results: Of 944 patients (mean age, 57.8 years; 49% male), 18.9% had CMT at or below the L1-L2 interspace, and spinal anesthesia at the L2-L3 interspace was found to carry a 0.7% incidence of neuraxial risk. Only the presence of congenital spinal abnormalities was found to be significantly predictive of having a CMT at or below the L1-L2 interspace. TL was found to correspond to the L4-L5 interspace in 99.8% of patients with lumbar x-rays.

Conclusions: Spinal anesthesia at the L2-L3 interspace, using TL as an anatomical landmark, is safe in >99% of patients. However, caution must be exercised in all patients as demographic variables were found to be limited in predicting a low CMT level.

Editorial comment: Unlike previous smaller studies, this retrospective study included MRI data from a total of 944 patients. The present study confirms that spinal anesthesia at the L2-L3 interspace or below can be considered safe. The findings indicate that Tuffier's line can be used as a reliable anatomical landmark.

背景:传统的教学是在L2-L3间隙或以下的脊髓麻醉是安全的。为了评估这一点,我们试图确定髓圆锥终止(CMT)水平在L1-L2间隙或低于L1-L2间隙的个体百分比。此外,CMT水平与年龄、性别、身体质量指数(BMI)和脊柱病理的关系被检查,以及使用Tuffier线(TL)作为解剖学标志的可靠性。方法:回顾性研究944例成年患者的磁共振图像,以确定CMT水平。采用logistic回归方法探讨年龄、性别、身高、BMI、脊柱病理与CMT水平的关系。使用同一患者队列的720张腰椎x线检查了TL线与L4-L5间隙的对应关系以及与CMT重叠的存在。结果:944例患者(平均年龄57.8岁;(49%男性),18.9%的CMT位于L1-L2间隙或以下,L2-L3间隙的脊髓麻醉发生率为0.7%。只有先天性脊柱异常的存在被发现是在L1-L2间隙或以下发生CMT的显著预测因素。在99.8%的腰x线患者中发现TL与L4-L5间隙相对应。结论:在L2-L3间隙进行脊髓麻醉,以TL为解剖标志,对99%的患者是安全的。然而,必须谨慎对待所有患者,因为发现人口统计学变量在预测低CMT水平方面是有限的。编者评论:与以往的小型研究不同,这项回顾性研究包括了944名患者的MRI数据。本研究证实L2-L3间隙或以下的脊髓麻醉是安全的。研究结果表明,Tuffier线可以作为可靠的解剖学标志。
{"title":"Conus medullaris termination: Assessing safety of spinal anesthesia in the L2-L3 interspace.","authors":"James E Paul, Lisa A Udovic, Kathleen Oman, Thomas Kim, Leora Bernstein, Luigi Matteliano, Nina Singh, Alexa Caldwell, Thuva Vanniyasingam, Lehana Thabane","doi":"10.1111/aas.14580","DOIUrl":"10.1111/aas.14580","url":null,"abstract":"<p><strong>Background: </strong>Classic teaching is that spinal anesthesia is safe at or below the L2-L3 interspace. To evaluate this, we sought to determine the percentage of individuals with a conus medullaris termination (CMT) level at or below the L1-L2 interspace. Further, the relationship of CMT level to age, sex, body mass index (BMI), and spinal pathology was examined, as was the reliability of using Tuffier's line (TL) as an anatomical landmark.</p><p><strong>Methods: </strong>This retrospective study evaluated magnetic resonance images of 944 adult patients to determine the CMT level. The relationship between age, sex, height, BMI, and spinal pathology and CMT level was explored by logistic regression. The correspondence of the TL line to the L4-L5 interspace and the presence of overlap with the CMT were examined using 720 lumbar x-rays of the same patient cohort.</p><p><strong>Results: </strong>Of 944 patients (mean age, 57.8 years; 49% male), 18.9% had CMT at or below the L1-L2 interspace, and spinal anesthesia at the L2-L3 interspace was found to carry a 0.7% incidence of neuraxial risk. Only the presence of congenital spinal abnormalities was found to be significantly predictive of having a CMT at or below the L1-L2 interspace. TL was found to correspond to the L4-L5 interspace in 99.8% of patients with lumbar x-rays.</p><p><strong>Conclusions: </strong>Spinal anesthesia at the L2-L3 interspace, using TL as an anatomical landmark, is safe in >99% of patients. However, caution must be exercised in all patients as demographic variables were found to be limited in predicting a low CMT level.</p><p><strong>Editorial comment: </strong>Unlike previous smaller studies, this retrospective study included MRI data from a total of 944 patients. The present study confirms that spinal anesthesia at the L2-L3 interspace or below can be considered safe. The findings indicate that Tuffier's line can be used as a reliable anatomical landmark.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14580"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11780305/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143062972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intubating conditions during rapid sequence induction with either rocuronium or suxamethonium in elderly patients. A randomised study. 老年患者罗库溴铵或苏沙霉素快速序列诱导时的插管条件。一项随机研究。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14589
Matias Vested, Andreas Creutzburg, Christian S Meyhoff, Marie Louise Rovsing, Tatiana Nielsen, Fabio Rosa, Eske K Aasvang, Hannah Mollerup, Thomas Fuchs-Buder, Lars Simon Rasmussen

Background: During rapid sequence induction, either rocuronium 1.0 mg kg-1 or suxamethonium 1.0 mg kg-1 can be administered to facilitate endotracheal intubation. We hypothezised that rocuronium provided a larger proportion of excellent intubating conditions compared to suxamethonium in elderly patients.

Methods: A total of 90 patients 80 years or above with American Society of Anesthesiologists physical health Classes I-IV, and a body mass index < 35 kg m-1-2 were randomised to either rocuronium 1.0 mg kg-1 or suxamethonium 1.0 mg kg-1 during rapid sequence induction with intubation using a video laryngoscope. After 60 s, tracheal intubating conditions were evaluated using the Fuchs-Buder scale by a blinded investigator, and the primary outcome was the proportion of patients with excellent intubating conditions. Further outcomes included first pass success rate, intubating conditions according to the intubating difficulty scale (IDS), onset time and postoperative occurrence of muscle soreness, hoarseness and sore throat.

Results: All patients were evaluated for the primary outcome. Excellent intubating conditions occurred in 36 patients (73%) versus 31 (75%) in the rocuronium group and suxamethonium group, respectively (95% confidence interval [CI]: -16 to 20) (p = .82). The first pass success rate was 48 (98%) versus 40 (98%) comparing the rocuronium group with the suxamethonium group, respectively (p = .90). No difference in IDS score was found; median 0 (interquartile ranges [IQR]: 0-1) versus median 0 (IQR: 0-1) (p = .48). Onset time was significantly shorter in the suxamethonium group 99 versus 131 s (p = .01) (95% CI: 7 to 57). Finally, no difference was found in the occurrence of muscle soreness, hoarseness or sore throat postoperatively.

Conclusion: No important difference in intubating conditions was found during rapid sequence induction after the administration of either rocuronium 1.0 mg kg-1 or suxamethonium 1.0 mg kg-1 in patients 80 years or above.

Editorial comment: This reports a superiority trial comparing standardised doses of rocuronium and suxamethonium at 60 s for quality of intubating conditions in the rapid sequence context, and this in an elderly cohort. The findings showed no difference between the drugs concerning intubation outcomes, though the onset or time to peak effect was shorter for suxamethonium, again demonstrated in a cohort 80 years old or older.

背景:在快速序列诱导过程中,罗库溴铵1.0 mg kg-1或苏沙莫铵1.0 mg kg-1均可用于气管插管。我们假设在老年患者中,罗库溴铵比苏沙霉素提供了更大比例的良好插管条件。方法:90例80岁及以上、美国麻醉医师学会身体健康等级为I-IV级、体重指数为-1-2的患者在视频喉镜下快速序贯诱导时随机分为罗库溴铵1.0 mg kg-1组和苏沙莫铵1.0 mg kg-1组。60岁后,由盲法研究者采用Fuchs-Buder量表评估气管插管情况,主要观察指标为气管插管情况良好的患者比例。进一步的结果包括首次通过成功率、插管困难量表(IDS)的插管条件、发病时间和术后肌肉酸痛、声音嘶哑和喉咙痛的发生情况。结果:所有患者均进行了主要预后评估。罗库溴铵组和苏沙霉素组插管情况良好的患者分别为36例(73%)和31例(75%)(95%可信区间[CI]: -16 ~ 20) (p = .82)。罗库溴铵组和苏沙霉素组的首次通过率分别为48(98%)和40 (98%)(p = 0.90)。IDS评分差异无统计学意义;中位数0(四分位数间距[IQR]: 0-1)与中位数0 (IQR: 0-1) (p = 0.48)。suxamethonium组的起效时间明显短于131 s (p = 0.01) (95% CI: 7 ~ 57)。最后,在术后肌肉酸痛、声音嘶哑或喉咙痛的发生方面没有发现差异。结论:80岁及以上患者应用罗库溴铵1.0 mg kg-1与苏沙莫铵1.0 mg kg-1后,快速序列诱导时插管情况无显著差异。编者按:这篇报道了一项优越性试验,比较了60秒时标准剂量的罗库溴铵和苏沙莫铵在快速序列背景下的插管条件质量,该试验在老年队列中进行。研究结果显示,两种药物在插管结果方面没有差异,尽管suxamethonium的发病时间或达到峰值的时间更短,这再次在80岁或以上的队列中得到证实。
{"title":"Intubating conditions during rapid sequence induction with either rocuronium or suxamethonium in elderly patients. A randomised study.","authors":"Matias Vested, Andreas Creutzburg, Christian S Meyhoff, Marie Louise Rovsing, Tatiana Nielsen, Fabio Rosa, Eske K Aasvang, Hannah Mollerup, Thomas Fuchs-Buder, Lars Simon Rasmussen","doi":"10.1111/aas.14589","DOIUrl":"10.1111/aas.14589","url":null,"abstract":"<p><strong>Background: </strong>During rapid sequence induction, either rocuronium 1.0 mg kg<sup>-1</sup> or suxamethonium 1.0 mg kg<sup>-1</sup> can be administered to facilitate endotracheal intubation. We hypothezised that rocuronium provided a larger proportion of excellent intubating conditions compared to suxamethonium in elderly patients.</p><p><strong>Methods: </strong>A total of 90 patients 80 years or above with American Society of Anesthesiologists physical health Classes I-IV, and a body mass index < 35 kg m<sup>-1-2</sup> were randomised to either rocuronium 1.0 mg kg<sup>-1</sup> or suxamethonium 1.0 mg kg<sup>-1</sup> during rapid sequence induction with intubation using a video laryngoscope. After 60 s, tracheal intubating conditions were evaluated using the Fuchs-Buder scale by a blinded investigator, and the primary outcome was the proportion of patients with excellent intubating conditions. Further outcomes included first pass success rate, intubating conditions according to the intubating difficulty scale (IDS), onset time and postoperative occurrence of muscle soreness, hoarseness and sore throat.</p><p><strong>Results: </strong>All patients were evaluated for the primary outcome. Excellent intubating conditions occurred in 36 patients (73%) versus 31 (75%) in the rocuronium group and suxamethonium group, respectively (95% confidence interval [CI]: -16 to 20) (p = .82). The first pass success rate was 48 (98%) versus 40 (98%) comparing the rocuronium group with the suxamethonium group, respectively (p = .90). No difference in IDS score was found; median 0 (interquartile ranges [IQR]: 0-1) versus median 0 (IQR: 0-1) (p = .48). Onset time was significantly shorter in the suxamethonium group 99 versus 131 s (p = .01) (95% CI: 7 to 57). Finally, no difference was found in the occurrence of muscle soreness, hoarseness or sore throat postoperatively.</p><p><strong>Conclusion: </strong>No important difference in intubating conditions was found during rapid sequence induction after the administration of either rocuronium 1.0 mg kg<sup>-1</sup> or suxamethonium 1.0 mg kg<sup>-1</sup> in patients 80 years or above.</p><p><strong>Editorial comment: </strong>This reports a superiority trial comparing standardised doses of rocuronium and suxamethonium at 60 s for quality of intubating conditions in the rapid sequence context, and this in an elderly cohort. The findings showed no difference between the drugs concerning intubation outcomes, though the onset or time to peak effect was shorter for suxamethonium, again demonstrated in a cohort 80 years old or older.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14589"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11798891/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143254457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of plasma concentration and sedative effect of sublingual and intranasal dexmedetomidine in children: A double-blind randomised controlled study. 儿童舌下和鼻内右美托咪定血药浓度和镇静作用的比较:一项双盲随机对照研究。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14583
Armanullah Khan, Renu Sinha, Kanil Ranjith Kumar, Trimurty Velpandian, Souvik Maitra, Bikash Ranjan Ray

Background: Pharmacokinetics and sedative effects of sublingual dexmedetomidine have not been established in children. The primary aim was to compare peak plasma concentration, time to reach peak plasma concentration and area under the curve with 2 μg/kg sublingual and intranasal dexmedetomidine. The secondary aims were to compare the depth of sedation, parental separation anxiety, mask acceptance, heart rate changes, analgesic requirements and recovery time with 2 μg/kg sublingual and intranasal dexmedetomidine in children.

Method: Thirty children between 2 and 12 years, weighing 10-30 kg, scheduled for surgeries were divided into two groups. Thirty minutes before the induction of anaesthesia, children were premedicated with 2 μg/kg dexmedetomidine either by intranasal drops (Group N) or sublingual wafer (Group S). Five venous blood samples were collected to measure dexmedetomidine plasma concentrations at 15, 30, 45, 60 and 120 min from dexmedetomidine administration. Sedation, parental separation anxiety, mask acceptance and heart rate were recorded. Recovery, pain and fentanyl requirements were assessed.

Results: Demographic data was comparable. Median interquartile range (IQR) dexmedetomidine peak plasma concentration in Group N (0.764 [0.650-0.820]) ng/mL was significantly higher than in Group S (0.593 [0.364-0.754]) ng/mL (p = .014). Plasma concentration was significantly higher at 30 and 45 min in Group N as compared to Group S (p < .05). The median (IQR) time to reach peak plasma concentration was shorter in Group N (45 [45-120]) minutes than in Group S (60 [45-60]) minutes, (p = .814). The median (IQR) area under the concentration-time curve was significantly higher in Group N (1.062 [0.848-1.20]) ng/mL.h in comparison to Group S (0.866 [0.520-1.05]) ng/mL.h (p = .031). Comparable sedation was achieved at 25 min in both groups. No child required treatment for decreased heart rate. Parental separation anxiety, mask acceptance, recovery and analgesic requirements were comparable.

Conclusions: Intranasal 2 μg/kg dexmedetomidine resulted in significantly higher peak plasma concentration and time to reach peak plasma concentration than sublingual wafers. Sublingual and intranasal dexmedetomidine resulted in comparable sedation, parental separation and mask acceptance.

Editorial comment: This study compared the pharmacokinetics and sedative effects of sublingual versus intranasal dexmedetomidine in children, finding that intranasal administration resulted in significantly higher peak plasma concentration and faster time to peak concentration. Both routes achieved comparable sedation, parental separation anxiety scores and mask acceptance, with no significant adverse effects observed.

背景:舌下右美托咪定在儿童中的药代动力学和镇静作用尚未确定。主要目的是比较2 μg/kg舌下和鼻内右美托咪定的血药峰浓度、血药峰到达时间和曲线下面积。次要目的是比较2 μg/kg舌下和鼻内右美托咪定对儿童的镇静深度、父母分离焦虑、面罩接受度、心率变化、镇痛需求和恢复时间。方法:将30例2 ~ 12岁,体重10 ~ 30kg的拟手术患儿分为两组。麻醉诱导前30分钟,患儿分别给予2 μg/kg右美托咪定鼻滴剂(N组)和舌下滴剂(S组),分别于给药后15、30、45、60和120 min采集5份静脉血,测定右美托咪定血药浓度。记录镇静、父母分离焦虑、口罩接受度和心率。评估恢复、疼痛和芬太尼需求。结果:人口统计学数据具有可比性。N组右美托咪定血药峰浓度中位数四分位数范围(IQR) (0.764 [0.650-0.820]) ng/mL显著高于S组(0.593 [0.364-0.754])ng/mL (p = 0.014)。结论:2 μg/kg右美托咪定鼻内给药可显著延长血药峰浓度及到达血药峰时间。舌下和鼻内右美托咪定的镇静、父母分离和口罩接受度相当。编辑评论:本研究比较了儿童舌下和鼻内右美托咪定的药代动力学和镇静作用,发现鼻内给药显著更高的血药峰浓度和更快的达到血药峰浓度的时间。两种方法均取得了相当的镇静效果、父母分离焦虑评分和口罩接受度,未观察到明显的不良反应。
{"title":"Comparison of plasma concentration and sedative effect of sublingual and intranasal dexmedetomidine in children: A double-blind randomised controlled study.","authors":"Armanullah Khan, Renu Sinha, Kanil Ranjith Kumar, Trimurty Velpandian, Souvik Maitra, Bikash Ranjan Ray","doi":"10.1111/aas.14583","DOIUrl":"10.1111/aas.14583","url":null,"abstract":"<p><strong>Background: </strong>Pharmacokinetics and sedative effects of sublingual dexmedetomidine have not been established in children. The primary aim was to compare peak plasma concentration, time to reach peak plasma concentration and area under the curve with 2 μg/kg sublingual and intranasal dexmedetomidine. The secondary aims were to compare the depth of sedation, parental separation anxiety, mask acceptance, heart rate changes, analgesic requirements and recovery time with 2 μg/kg sublingual and intranasal dexmedetomidine in children.</p><p><strong>Method: </strong>Thirty children between 2 and 12 years, weighing 10-30 kg, scheduled for surgeries were divided into two groups. Thirty minutes before the induction of anaesthesia, children were premedicated with 2 μg/kg dexmedetomidine either by intranasal drops (Group N) or sublingual wafer (Group S). Five venous blood samples were collected to measure dexmedetomidine plasma concentrations at 15, 30, 45, 60 and 120 min from dexmedetomidine administration. Sedation, parental separation anxiety, mask acceptance and heart rate were recorded. Recovery, pain and fentanyl requirements were assessed.</p><p><strong>Results: </strong>Demographic data was comparable. Median interquartile range (IQR) dexmedetomidine peak plasma concentration in Group N (0.764 [0.650-0.820]) ng/mL was significantly higher than in Group S (0.593 [0.364-0.754]) ng/mL (p = .014). Plasma concentration was significantly higher at 30 and 45 min in Group N as compared to Group S (p < .05). The median (IQR) time to reach peak plasma concentration was shorter in Group N (45 [45-120]) minutes than in Group S (60 [45-60]) minutes, (p = .814). The median (IQR) area under the concentration-time curve was significantly higher in Group N (1.062 [0.848-1.20]) ng/mL.h in comparison to Group S (0.866 [0.520-1.05]) ng/mL.h (p = .031). Comparable sedation was achieved at 25 min in both groups. No child required treatment for decreased heart rate. Parental separation anxiety, mask acceptance, recovery and analgesic requirements were comparable.</p><p><strong>Conclusions: </strong>Intranasal 2 μg/kg dexmedetomidine resulted in significantly higher peak plasma concentration and time to reach peak plasma concentration than sublingual wafers. Sublingual and intranasal dexmedetomidine resulted in comparable sedation, parental separation and mask acceptance.</p><p><strong>Editorial comment: </strong>This study compared the pharmacokinetics and sedative effects of sublingual versus intranasal dexmedetomidine in children, finding that intranasal administration resulted in significantly higher peak plasma concentration and faster time to peak concentration. Both routes achieved comparable sedation, parental separation anxiety scores and mask acceptance, with no significant adverse effects observed.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14583"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143062866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tactical Emergency Medical Services in Copenhagen, Denmark: A mixed methods design study introducing a new concept. 丹麦哥本哈根战术紧急医疗服务:一项引入新概念的混合方法设计研究。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.70003
Jonas Erasmus Egede Glahn, Kim Minh Michael Heltø, Henrik Alstrøm, Marian Christin Petersen, Rune Gärtner

Aims and objectives: The purpose of this study was to introduce the concept of Tactical Emergency Medical Services (TEMS) in Denmark and to explore the TEMS providers' and the Danish Police Forces' confidence in the TEMS concept in case of a terrorist attack within the Capital Region of Denmark.

Background: Terrorist attacks pose a major challenge to prehospital emergency medical services when it comes to reaching trapped victims. The threat to healthcare professionals limits access and creates a so-called therapeutic vacuum, leading to delayed treatment and evacuation of victims and ultimately increases mortality.

Methods: This study used a mixed methods triangulation approach, integrating qualitative data from an interview study and quantitative data from a register study. The interview study consisted of 18 semistructured interviews conducted across three interview groups (Copenhagen TEMS physicians/paramedics, senior on-site commanders, and tactical and medical officers from the Copenhagen Police Department) with six participants in each group. Data from the interview study were analyzed using thematic framework analysis. The register study used data from the TEMS database, including 61 assignments from 2019 to 2020, that were analyzed using descriptive statistics.

Results: The interview study found three core themes in each interview group. The main findings included insights on the advantages of having healthcare professionals in the warm zone, the prerequisites for the concept's success, TEMS's cooperation with the Danish Police Force, and challenges concerning healthcare providers inside tactical zones. The participants expected TEMS' presence inside the warm zone could improve triage and medical treatment, free police resources, increase police safety, optimize preparedness of the health sector, and significantly reduce the therapeutic vacuum. Data from the register study demonstrated that TEMS have had prior assignments in the warm and hot zones.

Conclusion: All participating groups have high confidence in TEMS to close the gap of the therapeutic vacuum and deliver advanced physician and paramedic-based tactical medicine inside the warm zone in case of a terrorist attack in Copenhagen, Denmark.

Editorial comment: This study includes both provider interviews and registry data to support insight into processes of Tactical Emergency Medicine. The authors discuss possible advantages of having emergency medical personnel in the major incident area early to support a coordinated response.

目的和目标:本研究的目的是在丹麦介绍战术紧急医疗服务(TEMS)的概念,并探讨TEMS提供者和丹麦警察部队在丹麦首都地区发生恐怖袭击时对TEMS概念的信心。背景:恐怖袭击对院前紧急医疗服务在接触被困受害者方面构成重大挑战。对保健专业人员的威胁限制了他们的获取,造成了所谓的治疗真空,导致延迟治疗和受害者撤离,最终增加了死亡率。方法:本研究采用混合方法三角测量方法,整合访谈研究的定性数据和登记研究的定量数据。访谈研究包括在三个访谈组(哥本哈根TEMS医生/护理人员、现场高级指挥官和哥本哈根警察局的战术和医疗官员)中进行的18次半结构化访谈,每组有6名参与者。访谈研究的数据采用主题框架分析。注册研究使用的数据来自TEMS数据库,包括2019年至2020年的61份作业,并使用描述性统计进行分析。结果:访谈研究发现每个访谈组有三个核心主题。主要调查结果包括:在温暖地区拥有医疗保健专业人员的优势、该概念成功的先决条件、TEMS与丹麦警察部队的合作,以及战术区域内医疗保健提供者面临的挑战。与会者期望TEMS在温暖区内的存在可以改善分诊和医疗,释放警察资源,提高警察安全,优化卫生部门的准备工作,并显著减少治疗真空。注册研究的数据表明,TEMS在温暖地区和炎热地区都有前科。结论:在丹麦哥本哈根发生恐怖袭击的情况下,所有参与小组都对TEMS填补治疗真空的空白,在温暖区域内提供先进的医生和护理人员为基础的战术医学有很高的信心。编辑评论:本研究包括提供者访谈和注册数据,以支持对战术急救医学过程的洞察。作者讨论了在重大事件发生地区尽早部署紧急医疗人员以支持协调响应的可能优势。
{"title":"Tactical Emergency Medical Services in Copenhagen, Denmark: A mixed methods design study introducing a new concept.","authors":"Jonas Erasmus Egede Glahn, Kim Minh Michael Heltø, Henrik Alstrøm, Marian Christin Petersen, Rune Gärtner","doi":"10.1111/aas.70003","DOIUrl":"10.1111/aas.70003","url":null,"abstract":"<p><strong>Aims and objectives: </strong>The purpose of this study was to introduce the concept of Tactical Emergency Medical Services (TEMS) in Denmark and to explore the TEMS providers' and the Danish Police Forces' confidence in the TEMS concept in case of a terrorist attack within the Capital Region of Denmark.</p><p><strong>Background: </strong>Terrorist attacks pose a major challenge to prehospital emergency medical services when it comes to reaching trapped victims. The threat to healthcare professionals limits access and creates a so-called therapeutic vacuum, leading to delayed treatment and evacuation of victims and ultimately increases mortality.</p><p><strong>Methods: </strong>This study used a mixed methods triangulation approach, integrating qualitative data from an interview study and quantitative data from a register study. The interview study consisted of 18 semistructured interviews conducted across three interview groups (Copenhagen TEMS physicians/paramedics, senior on-site commanders, and tactical and medical officers from the Copenhagen Police Department) with six participants in each group. Data from the interview study were analyzed using thematic framework analysis. The register study used data from the TEMS database, including 61 assignments from 2019 to 2020, that were analyzed using descriptive statistics.</p><p><strong>Results: </strong>The interview study found three core themes in each interview group. The main findings included insights on the advantages of having healthcare professionals in the warm zone, the prerequisites for the concept's success, TEMS's cooperation with the Danish Police Force, and challenges concerning healthcare providers inside tactical zones. The participants expected TEMS' presence inside the warm zone could improve triage and medical treatment, free police resources, increase police safety, optimize preparedness of the health sector, and significantly reduce the therapeutic vacuum. Data from the register study demonstrated that TEMS have had prior assignments in the warm and hot zones.</p><p><strong>Conclusion: </strong>All participating groups have high confidence in TEMS to close the gap of the therapeutic vacuum and deliver advanced physician and paramedic-based tactical medicine inside the warm zone in case of a terrorist attack in Copenhagen, Denmark.</p><p><strong>Editorial comment: </strong>This study includes both provider interviews and registry data to support insight into processes of Tactical Emergency Medicine. The authors discuss possible advantages of having emergency medical personnel in the major incident area early to support a coordinated response.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e70003"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11832305/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143439698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical leadership education-A scoping review protocol. 临床领导教育-范围审查方案。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14591
Naja Vaaben, Peter Dieckmann, Ann Merete Møller

Introduction: Leadership is a key skill for physicians, but studies show that many junior doctors feel unprepared for the role as a leader. In recent years, there has been increasing interest and research into the training and development of clinical leadership, revolving around leadership in situations with direct patient care and as opposed to the administrative leadership of a department. However, the lack of consensus on how best to teach leadership, how the education should be structured, as well as a standardized definition and measure for good leadership, complicates training, assessment, and comparison of approaches in both research and education.

Objective: The aim of this study is to map out the existing body of research on leadership education for physicians and medical students and identify any gaps in this literature.

Methods: The scoping review will follow the Arksey and O'Malley (Arksey and O'Malley, Int J Soc Res Methodol. 2005; 8(1):19-32) framework, Joanna Briggs Institute methodology (JBI Manual for Evidence Synthesis-JBI Global Wiki) and PRISMA_ScR (Tricco et al., Ann Intern Med. 2018; 169(7):467-473). A systematic search will be conducted across the following databases: PubMed, Cochrane, Embase, Ebsco, Medline, and Google scholar. Two independent reviewers will screen titles and abstracts, then review the full texts of articles. Data will be extracted and presented in line with the review questions.

Strengths and limitations of this study: The study will use a structured approach, as guided by Arksey and O'Malley and JBI methodology. Studies not written in English, Danish, German, Swedish, and Norwegian will be translated using available software. This review will not include a formal assessment of the study quality or meta-analysis, as it is a scoping review.

导言:领导力是医生的一项关键技能,但研究表明,许多初级医生认为自己还没有做好担任领导者的准备。近年来,人们对临床领导力的培训和发展越来越感兴趣,并开展了越来越多的研究,这些研究围绕着在直接照顾病人的情况下的领导力,而不是一个部门的行政领导力。然而,在如何最好地教授领导力、如何构建教育结构以及良好领导力的标准化定义和衡量标准方面缺乏共识,这使得培训、评估以及研究和教育方法的比较变得复杂:本研究的目的是对医生和医学生领导力教育的现有研究进行梳理,并找出文献中的空白点:方法:范围界定审查将遵循Arksey和O'Malley(Arksey和O'Malley,Int J Soc Res Methodol.2005;8(1):19-32)框架、乔安娜-布里格斯研究所方法学(JBI Manual for Evidence Synthesis-JBI Global Wiki)和PRISMA_ScR(Tricco et al.2018; 169(7):467-473).将在以下数据库中进行系统检索:PubMed、Cochrane、Embase、Ebsco、Medline 和 Google scholar。两名独立审稿人将筛选标题和摘要,然后审阅文章全文。本研究的优势和局限:本研究将采用 Arksey 和 O'Malley 以及 JBI 方法指导下的结构化方法。非英语、丹麦语、德语、瑞典语和挪威语撰写的研究报告将使用现有软件进行翻译。本综述不包括对研究质量的正式评估或荟萃分析,因为它只是范围界定综述。
{"title":"Clinical leadership education-A scoping review protocol.","authors":"Naja Vaaben, Peter Dieckmann, Ann Merete Møller","doi":"10.1111/aas.14591","DOIUrl":"10.1111/aas.14591","url":null,"abstract":"<p><strong>Introduction: </strong>Leadership is a key skill for physicians, but studies show that many junior doctors feel unprepared for the role as a leader. In recent years, there has been increasing interest and research into the training and development of clinical leadership, revolving around leadership in situations with direct patient care and as opposed to the administrative leadership of a department. However, the lack of consensus on how best to teach leadership, how the education should be structured, as well as a standardized definition and measure for good leadership, complicates training, assessment, and comparison of approaches in both research and education.</p><p><strong>Objective: </strong>The aim of this study is to map out the existing body of research on leadership education for physicians and medical students and identify any gaps in this literature.</p><p><strong>Methods: </strong>The scoping review will follow the Arksey and O'Malley (Arksey and O'Malley, Int J Soc Res Methodol. 2005; 8(1):19-32) framework, Joanna Briggs Institute methodology (JBI Manual for Evidence Synthesis-JBI Global Wiki) and PRISMA_ScR (Tricco et al., Ann Intern Med. 2018; 169(7):467-473). A systematic search will be conducted across the following databases: PubMed, Cochrane, Embase, Ebsco, Medline, and Google scholar. Two independent reviewers will screen titles and abstracts, then review the full texts of articles. Data will be extracted and presented in line with the review questions.</p><p><strong>Strengths and limitations of this study: </strong>The study will use a structured approach, as guided by Arksey and O'Malley and JBI methodology. Studies not written in English, Danish, German, Swedish, and Norwegian will be translated using available software. This review will not include a formal assessment of the study quality or meta-analysis, as it is a scoping review.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14591"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11848231/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143481992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypotension after anesthesia induction in patients taking tricyclic antidepressants-A case series. 三环类抗抑郁药麻醉诱导后低血压的临床观察。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.70001
Mads Lodsgaard, Birgitte Bech Melchiors, Mogens Krøigaard, Lene Heise Garvey

Background: Hypotension is commonly observed after induction of anesthesia. Risk factors for intraoperative hypotension include higher ASA class, older age, propofol use, combined general/regional anesthesia, emergency surgery, and use of antihypertensives. Patients who are treated with tricyclic antidepressants (TCAs) may develop severe hypotension in connection with surgery and anesthesia, not responding to vasopressors such as phenylephrine and ephedrine, and use of adrenaline or noradrenaline are necessary to restore the blood pressure. Anaphylaxis may be suspected due to the rapid onset and resistance to usual treatments leading to referral for allergy investigation. The aim of this paper was to identify and describe the clinical characteristics of patients referred to the Danish Anesthesia Allergy Center (DAAC) with perioperative hypotension, without elevation in tryptase, and with negative allergy investigations, who were on regular treatment with TCAs. The pharmacological mechanism behind this phenomenon will also be explored.

Methods: Patients were identified from the DAAC database. Patients with hypotension (systolic blood pressure <75 mmHg) as the only symptom and negative allergy investigations and patients on antidepressants were included. The study period was 2011-2019.

Results: Ten patients were identified. Hypotension occurred after anesthesia induction, the median time from induction to the onset of hypotension was 7.5 min. Eight needed adrenaline or noradrenaline to restore blood pressure. No allergen was identified on detailed investigation and serum tryptase was not significantly elevated.

Conclusion: Monosymptomatic perioperative hypotension without a significant increase in serum tryptase can be caused by TCAs and this is an important differential diagnosis to anaphylaxis. In patients on regular treatment with TCA perioperative hypotension responds well to noradrenaline or adrenaline but less well to vasopressors such as phenylephrine and ephedrine used perioperatively.

背景:在麻醉诱导后经常观察到低血压。术中低血压的危险因素包括ASA等级较高、年龄较大、使用异丙酚、全身/区域联合麻醉、急诊手术和使用抗高血压药物。接受三环抗抑郁药(TCAs)治疗的患者在手术和麻醉时可能出现严重的低血压,对苯肾上腺素和麻黄素等血管加压药物无反应,需要使用肾上腺素或去甲肾上腺素来恢复血压。由于快速发病和对常规治疗的抵抗,可能怀疑过敏反应,导致转诊进行过敏调查。本文的目的是识别和描述丹麦麻醉过敏中心(DAAC)患者的临床特征,这些患者围手术期低血压,没有胰酶升高,过敏调查阴性,接受TCAs常规治疗。这一现象背后的药理学机制也将被探讨。方法:从DAAC数据库中筛选患者。低血压患者(收缩压)结果:确定10例患者。麻醉诱导后出现低血压,诱导至低血压发生的中位时间为7.5 min。8人需要肾上腺素或去甲肾上腺素来恢复血压。详细调查未发现过敏原,血清胰蛋白酶未明显升高。结论:TCAs可引起围手术期无明显胰酶升高的单症状性低血压,是鉴别过敏反应的重要指标。常规TCA治疗的围手术期低血压患者对去甲肾上腺素或肾上腺素反应良好,但对围手术期使用的血管加压剂如苯肾上腺素和麻黄碱反应较差。
{"title":"Hypotension after anesthesia induction in patients taking tricyclic antidepressants-A case series.","authors":"Mads Lodsgaard, Birgitte Bech Melchiors, Mogens Krøigaard, Lene Heise Garvey","doi":"10.1111/aas.70001","DOIUrl":"10.1111/aas.70001","url":null,"abstract":"<p><strong>Background: </strong>Hypotension is commonly observed after induction of anesthesia. Risk factors for intraoperative hypotension include higher ASA class, older age, propofol use, combined general/regional anesthesia, emergency surgery, and use of antihypertensives. Patients who are treated with tricyclic antidepressants (TCAs) may develop severe hypotension in connection with surgery and anesthesia, not responding to vasopressors such as phenylephrine and ephedrine, and use of adrenaline or noradrenaline are necessary to restore the blood pressure. Anaphylaxis may be suspected due to the rapid onset and resistance to usual treatments leading to referral for allergy investigation. The aim of this paper was to identify and describe the clinical characteristics of patients referred to the Danish Anesthesia Allergy Center (DAAC) with perioperative hypotension, without elevation in tryptase, and with negative allergy investigations, who were on regular treatment with TCAs. The pharmacological mechanism behind this phenomenon will also be explored.</p><p><strong>Methods: </strong>Patients were identified from the DAAC database. Patients with hypotension (systolic blood pressure <75 mmHg) as the only symptom and negative allergy investigations and patients on antidepressants were included. The study period was 2011-2019.</p><p><strong>Results: </strong>Ten patients were identified. Hypotension occurred after anesthesia induction, the median time from induction to the onset of hypotension was 7.5 min. Eight needed adrenaline or noradrenaline to restore blood pressure. No allergen was identified on detailed investigation and serum tryptase was not significantly elevated.</p><p><strong>Conclusion: </strong>Monosymptomatic perioperative hypotension without a significant increase in serum tryptase can be caused by TCAs and this is an important differential diagnosis to anaphylaxis. In patients on regular treatment with TCA perioperative hypotension responds well to noradrenaline or adrenaline but less well to vasopressors such as phenylephrine and ephedrine used perioperatively.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e70001"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11830959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative opioid administrations, rescue doses in the post-anaesthesia care unit and clinician-perceived factors for dose adjustments in adults: A Danish nationwide survey. 术中阿片类药物给药,麻醉后护理单位的抢救剂量和成人剂量调整的临床感知因素:丹麦全国调查。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.70000
Trang Xuan Minh Tran, Mik Wetterslev, Anders Kehlet Nørskov, Christian Sylvest Meyhoff, Markus Harboe Olsen, Theis Skovsgaard Itenov, Ole Mathiesen, Anders Peder Højer Karlsen

Background: The impact of demographic- and surgical factors on individual perioperative opioid requirements is not fully understood. Anaesthesia personnel adjust opioid administrations based on their own clinical experience, expert opinions and local guidelines. This survey aimed to assess the current practice of anaesthesia personnel regarding intraoperative opioid treatment for postoperative analgesia and rescue opioid dosing strategies in the post-anaesthesia care unit in Denmark.

Methods: We conducted a cross-sectional online survey with 37 questions addressing pain management and opioid-dosing strategies. Local site investigators from 46 of 47 public Danish anaesthesia departments distributed the survey. Data collection took place from 5 February to 30 April 2024.

Results: Of the 4187 survey participants, 2025 (48%) answered. Intra- and postoperative opioid doses were adjusted based on chronic pain, age, preoperative opioid use, body weight and type of surgery. Between 84% and 89% of respondents adhered to and had perioperative pain management guidelines available. Respondents preferred intraoperative fentanyl (44%) and morphine (36%) to prevent postoperative pain. Median intraoperative intravenous morphine equivalents ranged from 0.12 to 0.38 mg/kg in clinical scenarios. In these cases, the following variables were assembled in different combinations to assess their impact on dosing: age (30 vs. 65 years), sex (female vs. male), ASA score (1 vs. 3) and type of surgery (anterior cruciate ligament vs. laparoscopic cholecystectomy surgery). Respondents preferred intravenous morphine and fentanyl for moderate and severe postoperative pain, respectively. Median postoperative rescue doses were 0.06-0.12 mg/kg in clinical scenarios based on shifting combinations of the variables: age (30 vs. 65 years), ASA score (1 vs. 3) and degree of expected pain (moderate vs. severe).

Conclusion: Respondents preferred fentanyl and morphine for postoperative pain control with considerable variation in choice of opioid and morphine equivalent dose. Respondents expressed that guidelines were highly available and strongly adhered to. Opioid dosing was predominantly guided by chronic pain, age, preoperative opioid use, body weight and type of surgery.

背景:人口统计学和外科因素对个体围手术期阿片类药物需求的影响尚不完全清楚。麻醉人员根据自己的临床经验、专家意见和当地指南调整阿片类药物给药。本调查旨在评估目前丹麦麻醉人员对术中阿片类药物治疗术后镇痛的做法和麻醉后护理单位的阿片类药物剂量策略。方法:我们进行了一项横断面在线调查,共有37个问题,涉及疼痛管理和阿片类药物给药策略。来自47个丹麦公共麻醉部门中的46个的当地现场调查员分发了调查问卷。数据收集于2024年2月5日至4月30日进行。结果:在4187名调查对象中,有2025人(48%)回答了问题。根据慢性疼痛、年龄、术前阿片类药物使用、体重和手术类型调整手术内和术后阿片类药物剂量。84%至89%的应答者遵守并拥有围手术期疼痛管理指南。受访者更倾向于术中芬太尼(44%)和吗啡(36%)来预防术后疼痛。在临床情况下,术中静脉吗啡当量的中位数范围为0.12至0.38 mg/kg。在这些病例中,以下变量以不同的组合进行组合,以评估它们对剂量的影响:年龄(30岁vs 65岁)、性别(女性vs男性)、ASA评分(1 vs 3)和手术类型(前十字韧带vs腹腔镜胆囊切除术)。受访者分别倾向于静脉注射吗啡和芬太尼治疗中度和重度术后疼痛。根据年龄(30岁vs. 65岁)、ASA评分(1分vs. 3分)和预期疼痛程度(中度vs.重度)等变量的变化组合,临床情况下的术后抢救中位剂量为0.06-0.12 mg/kg。结论:受访者在阿片类药物和吗啡等效剂量的选择上差异较大,更倾向于芬太尼和吗啡用于术后疼痛控制。答复者表示,指导方针很容易获得并得到严格遵守。阿片类药物的剂量主要受慢性疼痛、年龄、术前阿片类药物使用、体重和手术类型的影响。
{"title":"Intraoperative opioid administrations, rescue doses in the post-anaesthesia care unit and clinician-perceived factors for dose adjustments in adults: A Danish nationwide survey.","authors":"Trang Xuan Minh Tran, Mik Wetterslev, Anders Kehlet Nørskov, Christian Sylvest Meyhoff, Markus Harboe Olsen, Theis Skovsgaard Itenov, Ole Mathiesen, Anders Peder Højer Karlsen","doi":"10.1111/aas.70000","DOIUrl":"10.1111/aas.70000","url":null,"abstract":"<p><strong>Background: </strong>The impact of demographic- and surgical factors on individual perioperative opioid requirements is not fully understood. Anaesthesia personnel adjust opioid administrations based on their own clinical experience, expert opinions and local guidelines. This survey aimed to assess the current practice of anaesthesia personnel regarding intraoperative opioid treatment for postoperative analgesia and rescue opioid dosing strategies in the post-anaesthesia care unit in Denmark.</p><p><strong>Methods: </strong>We conducted a cross-sectional online survey with 37 questions addressing pain management and opioid-dosing strategies. Local site investigators from 46 of 47 public Danish anaesthesia departments distributed the survey. Data collection took place from 5 February to 30 April 2024.</p><p><strong>Results: </strong>Of the 4187 survey participants, 2025 (48%) answered. Intra- and postoperative opioid doses were adjusted based on chronic pain, age, preoperative opioid use, body weight and type of surgery. Between 84% and 89% of respondents adhered to and had perioperative pain management guidelines available. Respondents preferred intraoperative fentanyl (44%) and morphine (36%) to prevent postoperative pain. Median intraoperative intravenous morphine equivalents ranged from 0.12 to 0.38 mg/kg in clinical scenarios. In these cases, the following variables were assembled in different combinations to assess their impact on dosing: age (30 vs. 65 years), sex (female vs. male), ASA score (1 vs. 3) and type of surgery (anterior cruciate ligament vs. laparoscopic cholecystectomy surgery). Respondents preferred intravenous morphine and fentanyl for moderate and severe postoperative pain, respectively. Median postoperative rescue doses were 0.06-0.12 mg/kg in clinical scenarios based on shifting combinations of the variables: age (30 vs. 65 years), ASA score (1 vs. 3) and degree of expected pain (moderate vs. severe).</p><p><strong>Conclusion: </strong>Respondents preferred fentanyl and morphine for postoperative pain control with considerable variation in choice of opioid and morphine equivalent dose. Respondents expressed that guidelines were highly available and strongly adhered to. Opioid dosing was predominantly guided by chronic pain, age, preoperative opioid use, body weight and type of surgery.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e70000"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11839308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143456553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring management reasoning when discharging high-risk postoperative patients from the post-anaesthesia care unit. 探讨高危术后患者从麻醉后护理病房出院时的管理推理。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14590
Lea Baunegaard Hvidberg, Hejdi Gamst-Jensen, Karlen Bader-Larsen, Nicolai Bang Foss, Eske Kvanner Aasvang, Martin Grønnebæk Tolsgaard

Introduction: Decision-support tools for detecting physiological deterioration are widely used in clinical medicine but have been criticised for fostering a task-oriented culture and reducing the emphasis on clinical reasoning. Little is understood about what influences clinical decisions aided by decision-support tools, including professional standards, policies, and contextual factors. Therefore, we explored management reasoning employed by anaesthesiologists and PACU nurses in the post-anaesthesia care unit during the discharge of high-risk postoperative patients.

Methods: A qualitative constructivist study, conducting 18 semi-structured with 6 anaesthesiologists and 12 nurses across three Danish teaching hospitals. We analysed data through thematic analysis, utilising Michael Lipsky's theory of "street-level bureaucracy" in combination with David A. Cook's Management Reasoning Framework as a sensitising concept.

Results: Standards are frequently ambiguous, requiring interpretation and prioritisation. This allows for professional discretion by circumventing established policies, reducing task-oriented culture and enhancing the clinical reasoning processes. However, discretion in management reasoning depends on whether the clinician is inclined to uphold or adjust policies to maintain professional standards, influencing discharge decisions.

Conclusion: While decision-support tools offer cognitive aid and help standardise patient trajectories, they also limit professional discretion in management reasoning and can potentially compromise care and treatment. This highlights the need for a balanced approach that considers both the benefits and limitations of these tools in clinical decision-making.

用于检测生理恶化的决策支持工具在临床医学中广泛使用,但因培养任务导向的文化和减少对临床推理的重视而受到批评。在决策支持工具(包括专业标准、政策和环境因素)的帮助下,对临床决策的影响知之甚少。因此,我们探讨麻醉医师和PACU护士在术后高危患者出院时麻醉后护理单元的管理推理。方法:采用质性建构主义研究方法,对丹麦三家教学医院的6名麻醉师和12名护士进行了18例半结构化研究。我们通过主题分析来分析数据,利用迈克尔·利普斯基的“街头官僚主义”理论,结合大卫·a·库克的管理推理框架作为一个敏感概念。结果:标准经常是模糊的,需要解释和优先级。这允许专业自由裁量权通过规避既定政策,减少以任务为导向的文化和加强临床推理过程。然而,管理推理的自由裁量权取决于临床医生是否倾向于维护或调整政策以保持专业标准,从而影响出院决定。结论:虽然决策支持工具提供了认知辅助并有助于规范患者轨迹,但它们也限制了管理推理的专业判断力,并可能损害护理和治疗。这突出了在临床决策中需要考虑到这些工具的优点和局限性的平衡方法。
{"title":"Exploring management reasoning when discharging high-risk postoperative patients from the post-anaesthesia care unit.","authors":"Lea Baunegaard Hvidberg, Hejdi Gamst-Jensen, Karlen Bader-Larsen, Nicolai Bang Foss, Eske Kvanner Aasvang, Martin Grønnebæk Tolsgaard","doi":"10.1111/aas.14590","DOIUrl":"10.1111/aas.14590","url":null,"abstract":"<p><strong>Introduction: </strong>Decision-support tools for detecting physiological deterioration are widely used in clinical medicine but have been criticised for fostering a task-oriented culture and reducing the emphasis on clinical reasoning. Little is understood about what influences clinical decisions aided by decision-support tools, including professional standards, policies, and contextual factors. Therefore, we explored management reasoning employed by anaesthesiologists and PACU nurses in the post-anaesthesia care unit during the discharge of high-risk postoperative patients.</p><p><strong>Methods: </strong>A qualitative constructivist study, conducting 18 semi-structured with 6 anaesthesiologists and 12 nurses across three Danish teaching hospitals. We analysed data through thematic analysis, utilising Michael Lipsky's theory of \"street-level bureaucracy\" in combination with David A. Cook's Management Reasoning Framework as a sensitising concept.</p><p><strong>Results: </strong>Standards are frequently ambiguous, requiring interpretation and prioritisation. This allows for professional discretion by circumventing established policies, reducing task-oriented culture and enhancing the clinical reasoning processes. However, discretion in management reasoning depends on whether the clinician is inclined to uphold or adjust policies to maintain professional standards, influencing discharge decisions.</p><p><strong>Conclusion: </strong>While decision-support tools offer cognitive aid and help standardise patient trajectories, they also limit professional discretion in management reasoning and can potentially compromise care and treatment. This highlights the need for a balanced approach that considers both the benefits and limitations of these tools in clinical decision-making.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14590"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143187634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A descriptive, retrospective single-centre study of air-leak syndrome in intensive care unit patients with COVID-19. COVID-19重症监护病房患者漏气综合征的描述性、回顾性单中心研究
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-03-01 DOI: 10.1111/aas.14582
Alice Löwing Jensen, Jacob Litorell, Jonathan Grip, Martin Dahlberg, Eva Joelsson-Alm, Sandra Jonmarker
<p><strong>Background: </strong>Acute respiratory failure is the predominant presentation of intensive care unit (ICU) patients with COVID-19, and lung protective strategies are recommended to mitigate additional respiratory complications such as air-leak syndrome. The aim of this study is to investigate the prevalence, type, and timing of air-leak syndrome with regards to associated factors and patient outcome in patients with COVID-19 in ICUs at a large Swedish emergency hospital.</p><p><strong>Methods: </strong>This retrospective study included all adult patients admitted to an ICU for COVID-19-related respiratory failure at Södersjukhuset between March 6, 2020, and June 6, 2021. Primary outcomes were proportion of patients diagnosed with air-leak syndrome and its different types of manifestations, and timing of diagnoses in relation to ICU admission and initiation of invasive ventilation. Secondary outcomes included the highest level of respiratory support prior to the diagnosis of air-leak syndrome, patient characteristics and treatment variables associated with air-leak syndrome, and 90-day mortality for patients with air-leak syndrome compared to those without.</p><p><strong>Results: </strong>Out of a total of 669 patients, 81 (12%) were diagnosed with air-leak syndrome. Air-leak syndrome manifested as pneumomediastinum (PMD) (n = 58, 72%), pneumothorax (PTX) (n = 43, 53%), subcutaneous emphysema (SCE) (n = 28, 35%) and pneumatocele (PC) (n = 4, 4.9%). Air-leak syndrome was diagnosed at a median of 14 days (IQR 6-22) after ICU admission and 12 days (IQR 6-19) following the initiation of invasive ventilation. The highest respiratory support prior to diagnosis was invasive ventilation (IV) in 64 patients (79%), non-invasive ventilation in two patients (2.5%), and low- or high-flow oxygen in 15 patients (19%). Multiple logistic regression showed that pulmonary disease at baseline (OR 1.87, 95% CI 1.07-3.25), a lower body mass index (OR 0.95, 95% CI 0.9-0.99), admission later compared with earlier in the pandemic (OR 3.89, 95% CI 2.14-7.08), and IV (OR 3.92, 95% CI 2.07-7.44) were associated with an increased risk of air-leak syndrome. Compared with patients not diagnosed with air-leak syndrome, patients with air-leaks had a higher mortality at 90 days after ICU admission, 46% versus 26% (p <.001). However, the mortality rate differed with different air-leak manifestations, 47% for PMD, 47% for PTX, 50% for the combination of both PMD and PTX and 0% in patients with only SCE and/or PC, respectively.</p><p><strong>Conclusion: </strong>In 669 ICU patients with COVID-19, 12% had one or more manifestations of air-leak syndrome. Notably, PMD, rather than PTX, was the most common manifestation, suggesting a potentially distinctive feature of COVID-19-related air-leak syndrome. Further research is needed to determine whether COVID-19 involves different pathophysiological or iatrogenic mechanisms compared with other critical respiratory conditions.</p
背景:急性呼吸衰竭是COVID-19重症监护病房(ICU)患者的主要表现,建议采取肺保护策略来减轻额外的呼吸并发症,如漏气综合征。本研究的目的是调查瑞典一家大型急救医院重症监护室COVID-19患者中漏气综合征的患病率、类型和时间与相关因素和患者预后的关系。方法:本回顾性研究纳入了2020年3月6日至2021年6月6日期间在Södersjukhuset因covid -19相关呼吸衰竭入住ICU的所有成年患者。主要观察指标为漏气综合征患者的比例及其不同类型的表现,以及诊断时间与ICU住院和开始有创通气的关系。次要结局包括漏气综合征诊断前的最高呼吸支持水平、与漏气综合征相关的患者特征和治疗变量,以及漏气综合征患者与无漏气综合征患者相比的90天死亡率。结果:669例患者中,81例(12%)被诊断为漏气综合征。漏气综合征表现为纵隔气肿(PMD) (n = 58, 72%)、气胸(n = 43, 53%)、皮下肺气肿(SCE) (n = 28, 35%)、气腹膨出(PC) (n = 4, 4.9%)。漏气综合征的诊断中位时间为ICU入院后14天(IQR 6-22),开始有创通气后12天(IQR 6-19)。诊断前最高的呼吸支持是有创通气(IV) 64例(79%),无创通气2例(2.5%),低流量或高流量吸氧15例(19%)。多元logistic回归显示,基线时肺部疾病(OR 1.87, 95% CI 1.07-3.25)、较低的体重指数(OR 0.95, 95% CI 0.99 -0.99)、入院时间较大流行早期晚(OR 3.89, 95% CI 2.14-7.08)和IV期(OR 3.92, 95% CI 2.07-7.44)与漏气综合征的风险增加相关。与未诊断为漏气综合征的患者相比,漏气患者在ICU入院后90天的死亡率更高,分别为46%和26% (p结论:在669例COVID-19 ICU患者中,12%的患者有一种或多种漏气综合征的表现。值得注意的是,PMD而不是PTX是最常见的表现,这表明与covid -19相关的漏气综合征可能具有独特的特征。与其他严重呼吸系统疾病相比,COVID-19是否涉及不同的病理生理或医源性机制,需要进一步研究。临床试验注册:Clinicaltrials.gov,识别号:NCT05877443。编者评论:这项关于通气COVID病例软组织漏气的单中心队列研究提出了相关因素和临床表现的发现,包括不同的COVID-19时期和治疗方法。
{"title":"A descriptive, retrospective single-centre study of air-leak syndrome in intensive care unit patients with COVID-19.","authors":"Alice Löwing Jensen, Jacob Litorell, Jonathan Grip, Martin Dahlberg, Eva Joelsson-Alm, Sandra Jonmarker","doi":"10.1111/aas.14582","DOIUrl":"10.1111/aas.14582","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Acute respiratory failure is the predominant presentation of intensive care unit (ICU) patients with COVID-19, and lung protective strategies are recommended to mitigate additional respiratory complications such as air-leak syndrome. The aim of this study is to investigate the prevalence, type, and timing of air-leak syndrome with regards to associated factors and patient outcome in patients with COVID-19 in ICUs at a large Swedish emergency hospital.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This retrospective study included all adult patients admitted to an ICU for COVID-19-related respiratory failure at Södersjukhuset between March 6, 2020, and June 6, 2021. Primary outcomes were proportion of patients diagnosed with air-leak syndrome and its different types of manifestations, and timing of diagnoses in relation to ICU admission and initiation of invasive ventilation. Secondary outcomes included the highest level of respiratory support prior to the diagnosis of air-leak syndrome, patient characteristics and treatment variables associated with air-leak syndrome, and 90-day mortality for patients with air-leak syndrome compared to those without.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Out of a total of 669 patients, 81 (12%) were diagnosed with air-leak syndrome. Air-leak syndrome manifested as pneumomediastinum (PMD) (n = 58, 72%), pneumothorax (PTX) (n = 43, 53%), subcutaneous emphysema (SCE) (n = 28, 35%) and pneumatocele (PC) (n = 4, 4.9%). Air-leak syndrome was diagnosed at a median of 14 days (IQR 6-22) after ICU admission and 12 days (IQR 6-19) following the initiation of invasive ventilation. The highest respiratory support prior to diagnosis was invasive ventilation (IV) in 64 patients (79%), non-invasive ventilation in two patients (2.5%), and low- or high-flow oxygen in 15 patients (19%). Multiple logistic regression showed that pulmonary disease at baseline (OR 1.87, 95% CI 1.07-3.25), a lower body mass index (OR 0.95, 95% CI 0.9-0.99), admission later compared with earlier in the pandemic (OR 3.89, 95% CI 2.14-7.08), and IV (OR 3.92, 95% CI 2.07-7.44) were associated with an increased risk of air-leak syndrome. Compared with patients not diagnosed with air-leak syndrome, patients with air-leaks had a higher mortality at 90 days after ICU admission, 46% versus 26% (p &lt;.001). However, the mortality rate differed with different air-leak manifestations, 47% for PMD, 47% for PTX, 50% for the combination of both PMD and PTX and 0% in patients with only SCE and/or PC, respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;In 669 ICU patients with COVID-19, 12% had one or more manifestations of air-leak syndrome. Notably, PMD, rather than PTX, was the most common manifestation, suggesting a potentially distinctive feature of COVID-19-related air-leak syndrome. Further research is needed to determine whether COVID-19 involves different pathophysiological or iatrogenic mechanisms compared with other critical respiratory conditions.&lt;/p","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":"69 3","pages":"e14582"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11816560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143397544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Anaesthesiologica Scandinavica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1